Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Zogenix Inc. (ZGNX)

30.06   -0.86 (-2.78%) 02-21 12:11
Open: 30.88 Pre. Close: 30.92
High: 30.9 Low: 29.57
Volume: 432,279 Market Cap: 1357M
Zogenix Inc is a pharmaceutical company engaged in commercializing & developing therapies that address clinical needs for people living with pain-related and CNS disorders that needs treatment alternatives to help return to normal daily functioning.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 31.443 - 31.594 31.594 - 31.73
Low: 29.971 - 30.145 30.145 - 30.304
Close: 30.632 - 30.919 30.919 - 31.18

Technical analysis

as of: 2020-02-21 12:01:42 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 54.42     One year: 66.83
Support: Support1: 29.41    Support2: 24.47
Resistance: Resistance1: 46.60    Resistance2: 57.22
Pivot: 37.86
Moving Average: MA(5): 30.73     MA(20): 41.04
MA(100): 45.95     MA(250): 45.22
MACD: MACD(12,26): -5.81     Signal(9): -4.69
Stochastic oscillator: %K(14,3): 4.38     %D(3): 4.84
RSI: RSI(14): 24.53
52-week: High: 57.22  Low: 29.41  Change(%): -38.4
Average Vol(K): 3-Month: 85666  10-Days: 236919

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ZGNX has closed above bottom band by 29.9%. Bollinger Bands are 364% wider than normal. The large width of the bands suggest high volatility as compared to ZGNX's normal range. The bands have been in this wide range for 16 bars. This is a sign that the current trend might continue.

Headline News

Tue, 18 Feb 2020 20:19:16 +0000
Noteworthy Tuesday Option Activity: FIVE, ADI, ZGNX

Tue, 11 Feb 2020 16:27:42 +0000
3 Beaten-Down Biotech Stocks With +50% Upside Potential

Fri, 07 Feb 2020 21:26:00 +0000
Notable Friday Option Activity: ZGNX, BYND, KOD

Fri, 07 Feb 2020 19:26:00 +0000
Zogenix's Positive Clinical Trial Wasn't Positive Enough

Thu, 26 Dec 2019 11:06:00 +0000
Down 43% in 7 Months, Is GW Pharmaceuticals Now a Buy?

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 44.25
Shares Float (M) 35.08
% Held by Insiders 0.56
% Held by Institutions 111.95
Shares Short (K) 6270
Shares Short P. Month (K)

Stock Financials

EPS -9.090
Book Value (p.s.) 5.660
PEG Ratio -0.36
Profit Margin
Operating Margin -9131.43
Return on Assets (ttm) -18.0
Return on Equity (ttm) -97.8
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -3.484
Qtrly Earnings Growth
Operating Cash Flow (M) -105.31
Levered Free Cash Flow (M) -71.52

Stock Valuations

P/E -3.31
P/E Growth Ratio -0.03
P/BV 5.32
P/S 753.12
P/CF -12.66

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2015-06-30
Last Split Ratio 0.13
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.